Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions

被引:35
|
作者
Ricardo, Manuel G. [1 ]
Ali, Ameena M. [2 ]
Plewka, Jacek [3 ]
Surmiak, Ewa [3 ]
Labuzek, Beata [3 ]
Neochoritis, Constantinos G. [2 ,4 ]
Atmaj, Jack [2 ,3 ]
Skalniak, Lukasz [3 ]
Zhang, Ran [2 ]
Holak, Tad A. [3 ]
Groves, Matthew [2 ]
Rivera, Daniel G. [1 ]
Domling, Alexander [2 ]
机构
[1] Univ Havana, Fac Chem, Ctr Nat Prod Res, Havana, Cuba
[2] Univ Groningen, Dept Pharm, Drug Design Grp, Groningen, Netherlands
[3] Jagiellonian Univ, Fac Chem, Krakow, Poland
[4] Univ Crete, Dept Chem, Iraklion, Greece
基金
新加坡国家研究基金会;
关键词
cancer; HSQC NMR; p53-MDM2; X; stapled peptides; Ugi reaction; BETA-HAIRPIN; SIDE-CHAINS; P53; MDM2; MACROCYCLIZATION; BINDING; DESIGN; STABILITY; P53-MDM2; AFFINITY;
D O I
10.1002/anie.201916257
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Stapled peptides are chemical entities in-between biologics and small molecules, which have proven to be the solution to high affinity protein-protein interaction antagonism, while keeping control over pharmacological performance such as stability and membrane penetration. We demonstrate that the multicomponent reaction-based stapling is an effective strategy for the development of alpha-helical peptides with highly potent dual antagonistic action of MDM2 and MDMX binding p53. Such a potent inhibitory activity of p53-MDM2/X interactions was assessed by fluorescence polarization, microscale thermophoresis, and 2D NMR, while several cocrystal structures with MDM2 were obtained. This MCR stapling protocol proved efficient and versatile in terms of diversity generation at the staple, as evidenced by the incorporation of both exo- and endo-cyclic hydrophobic moieties at the side chain cross-linkers. The interaction of the Ugi-staple fragments with the target protein was demonstrated by crystallography.
引用
收藏
页码:5235 / 5241
页数:7
相关论文
共 50 条
  • [1] Peptide Inhibitors of Protein-Protein Interactions
    Friedler, Assaf
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [2] Peptide-based inhibitors of protein-protein interactions
    Wojcik, Paulina
    Berlicki, Lukasz
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 707 - 713
  • [3] Designing helical peptide inhibitors of protein-protein interactions
    Araghi, Raheleh Rezaei
    Keating, Amy E.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2016, 39 : 27 - 38
  • [4] Peptide-based covalent inhibitors of protein-protein interactions
    Paulussen, Felix M.
    Grossmann, Tom N.
    JOURNAL OF PEPTIDE SCIENCE, 2023, 29 (01)
  • [5] Computationally designed peptide inhibitors of protein-protein interactions in membranes
    Caputo, Gregory A.
    Litvinov, Rustem I.
    Li, Wei
    Bennett, Joel S.
    DeGrado, William F.
    Yin, Hang
    BIOCHEMISTRY, 2008, 47 (33) : 8600 - 8606
  • [6] Diversity of protein-protein interactions
    Nooren, IMA
    Thornton, JM
    EMBO JOURNAL, 2003, 22 (14): : 3486 - 3492
  • [7] Inhibitors of protein-protein interactions
    Ockey, DA
    Gadek, TR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (03) : 393 - 400
  • [8] MULTIVALENT PEPTIDE-POLYMER CONJUGATES AS INHIBITORS FOR PROTEIN-PROTEIN INTERACTIONS
    Fischer, C.
    Koschek, K.
    Bertazzon, M.
    Freund, C.
    Rademann, J.
    JOURNAL OF PEPTIDE SCIENCE, 2016, 22 : S108 - S108
  • [9] In-solution enrichment identifies peptide inhibitors of protein-protein interactions
    Touti, Faycal
    Gates, Zachary P.
    Bandyopdhyay, Anupam
    Lautrette, Guillaume
    Pentelute, Bradley L.
    NATURE CHEMICAL BIOLOGY, 2019, 15 (04) : 410 - +
  • [10] Peptiderive server: derive peptide inhibitors from protein-protein interactions
    Sedan, Yuval
    Marcu, Orly
    Lyskov, Sergey
    Schueler-Furman, Ora
    NUCLEIC ACIDS RESEARCH, 2016, 44 (W1) : W536 - W541